Neuland Laboratories- A dedicated 100% API provider.
01 1Neuland Laboratories Limited
02 1Esteve Quimica SA
01 1XANOMELINE TARTRATE
02 1Xanomeline Tartrate
01 1India
02 1Spain
Neuland Laboratories- A dedicated 100% API provider.
NDC Package Code : 58032-3003
Start Marketing Date : 2023-03-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57572-0727
Start Marketing Date : 2024-11-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A xanomeline tartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of xanomeline tartrate, including repackagers and relabelers. The FDA regulates xanomeline tartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. xanomeline tartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of xanomeline tartrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A xanomeline tartrate supplier is an individual or a company that provides xanomeline tartrate active pharmaceutical ingredient (API) or xanomeline tartrate finished formulations upon request. The xanomeline tartrate suppliers may include xanomeline tartrate API manufacturers, exporters, distributors and traders.
click here to find a list of xanomeline tartrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing xanomeline tartrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for xanomeline tartrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture xanomeline tartrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain xanomeline tartrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a xanomeline tartrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of xanomeline tartrate suppliers with NDC on PharmaCompass.
We have 2 companies offering xanomeline tartrate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
